Diabetic Ulcers Treatment Market Size - By Treatment Type (Wound Care Dressings, Wound Care Devices, Biologics), Ulcer Type (Foot Ulcer, Mouth, Skin), End-use (Hospitals, Ambulatory Surgical Centers, Homecare Settings) & Forecast 2023 - 2032

Diabetic Ulcers Treatment Market Size

Diabetic Ulcers Treatment Market was worth USD 9.3 billion in 2022 and is projected to grow at over 5.8% CAGR from 2023 to 2032 owing to the rising global incidence of diabetes.
 

Additionally, as the world's population continues to age, there is a higher likelihood of individuals developing chronic diseases such as diabetes, thereby fostering the industry growth. Moreover, increasing healthcare expenditure and several government initiatives, particularly in developing countries and a greater willingness to spend on advanced wound care treatment further contributes to overall business development.
 

COVID-19 Impact

The outbreak of COVID-19 pandemic had a negative impact on the diabetic ulcers treatment market, as the pandemic disrupted the healthcare system worldwide, causing significant delays in diagnosis and treatment of non-emergency disease conditions. This led to delayed diagnosis and treatment of diabetic ulcers, thereby impacting the industry. Also, lockdowns, restrictions on movement, and fear of contracting the virus limited people's access to healthcare services.
 

With growing emphasis on reducing in-person visits and promoting physical distancing, healthcare providers explored virtual consultations and remote monitoring technologies to manage and monitor diabetic ulcers. This shift impacted traditional treatment approaches. However, in the initial quarter of 2021 the market witnessed considerable surge in the demand for diabetic ulcers treatment owing to relaxation in COVID-19 related restrictions and commencement of elective surgical produces, thereby boosting the market outlook.
 

Diabetic Ulcers Treatment Market Trends

Increasing number of diabetic patients across the globe positively influencing the diabetic ulcers treatment market growth. High incidence of diabetic ulcers in these patients increases the demand for treatment. Several factors such as sedentary lifestyle and lack of physical activity contribute to obesity, thereby increases the risk of developing diabetes. Similarly, poor dietary choices, including excessive consumption of processed foods, sugary beverages, and high-calorie meals, lead to weight gain and the development of diabetes.
 

For instance, as per the International Diabetes Federation, in 2021, approximately 537 million adults had diabetes and the total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. Such high numbers of diabetic patients will contribute significantly towards the overall business expansion.
 

Diabetic Ulcers Treatment Industry Restraint

High cost of the therapy may hamper the diabetic ulcers treatment market progression. Diabetic ulcers often require long-term and specialized care, involving multiple healthcare professionals such as podiatrists, wound care specialists, and endocrinologists. These ulcers also require regular dressing changes and specialized wound care supplies such as antimicrobial dressings, bandages, antibiotics, topical ointments, and specialized diabetic footwear. The cost of these supplies further adds ups the overall cost.
 

Additionally, proper diagnosis and monitoring of diabetic ulcers involve various tests such as blood tests, X-rays, MRI, and Doppler ultrasounds. In severe cases, surgical interventions such as debridement or skin grafts may be necessary. These procedures are expensive and can significantly increase the overall treatment expenses.
 

Diabetic Ulcers Treatment Market Analysis

The wound care dressings segment held 54% share of the diabetic ulcers treatment market in 2022. Wound care dressings are most widely used in the treatment of diabetic ulcers. These dressing provide a barrier that shields the wound from dirt, bacteria, and other harmful microorganisms, thereby helping to prevent infection and promotes faster healing. Also, wound dressings such as hydrocolloid or hydrogel dressings help maintain an optimal moisture balance in the wound by absorbing excess exudate from the wound or provide moisture to dry wounds, creating a suitable environment for healing. Such aforementioned factors will promote high segmental growth.
 

The foot ulcer segment dominated the industry 88.8% share in 2022. High incidence of diabetic foot ulcers amongst diabetic patients aids in segmental growth. For example, as per the Diabetic foot epidemiology and demographics 2021, the incidence of diabetic foot ulcer is approximately 630 per 100,000 diabetic individuals worldwide. Similarly, as per the CDC, 12% of people with diabetes develop diabetic foot ulcers during their lifetime. Such high incidence of diabetic foot ulcers will supplement the business growth over the analysis period.
 

The hospitals sector led the diabetic ulcers treatment market with dominant valuation in 2022. Availability of specialized care in hospitals, patient cantered approach, well developed infrastructure, and easy access increase the flow of patients in hospitals. Also, favourable reimbursement scenarios, multidisciplinary approach, and the convenience of receiving various treatments or procedures under one roof in hospital settings attract patients to hospitals, thereby augmenting the sector growth.
 

North America diabetic ulcers treatment industry amassed over 38.3% market share in 2022 and is speculated to grow at considerable growth rate between 2023 and 2032. Flourishing market expansion can be attributed to the increasing prevalence of diabetes in the region. Diabetes rates have been rising steadily in North America due to factors such as sedentary lifestyles, unhealthy eating habits, and an aging population.
 

Also, advancements in medical technology and treatment options have improved the management and outcomes of diabetic ulcers. Similarly, awareness campaigns, educational initiatives, and improved understanding of diabetes management among healthcare professionals and patients aids in early detection and treatment of diabetic ulcers, thereby propelling the regional diabetic ulcers treatment market statistics.
 

Diabetic Ulcers Treatment Market Share

Major players operating in diabetic ulcers treatment industry include

• B. Braun Melsungen AG
• Smith & Nephew, Inc.
• Organogenesis Holdings Inc.
• Derma Sciences Inc.
• Integra LifeSciences
• Hill Rom Holdings Inc.
• Mölnlycke Health Care AB
• Coloplast Corp
• Cardinal Health
• ConvaTec Group Plc
• Tissue Regenix
• 3M Healthcare
• Medline Industries, Inc.

These leaders majorly adopt various strategies including collaborations, acquisitions, mergers, and partnerships to create a global footprint and sustain market competition.
 

Diabetic Ulcers Treatment Industry News:

• In April 2023, 3M Health Care's innovative 3M Veraflo therapy, with both 3M Veraflo cleanse choice complete dressing and 3M V.A.C. Veraflo cleanse choice dressing, received FDA clearance for hydromechanical removal of infectious materials, non-viable tissue, and wound debris. This helped the company to increase its treatment type offerings and introduce its treatment types in the market.
   
• In June 2022, Smith & Nephew opened a new R&D and manufacturing facility for its advanced wound management franchise in Hull, UK. This strategy helped the company advance its research activities and increase its production capacity.
   

This diabetic ulcers treatment market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032, for the following segments:

Click here to Buy Section of this Report

Market, By Treatment Type

• Wound Care Dressings
  • Antimicrobial Dressing
  • Alginate Dressing
  • Hydrogel Dressing
  • Foam Dressing
  • Film Dressing
  • Hydrocolloid Dressing
  • Others Wound Care Dressings
• Biologics
  • Skin Grafts and Substitutes
  • Growth Factors
• Wound Care Devices
  • Negative Pressure Wound Therapy
  • Hyperbaric Oxygen Therapy
  • Pressure Relief Devices
  • Electromagnetic Therapy
  • Ultrasound Therapy

Market, By Ulcer Type

• Foot Ulcer
  • Neuro-ischemic Ulcer
  • Neuropathic Ulcer
  • Ischemic Ulcer
• Mouth Ulcer
• Skin Ulcer
• Other Ulcer Types

Market, By End-use

• Hospitals
• Ambulatory Surgical Centers
• Homecare Settings

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of MEA